Skip to main content
TipRanks
Go Ultimate75% OFF

Innovation Pharmaceuticals (IPIX) Financial Statements

134 Followers

Innovation Pharmaceuticals Financial Overview

Innovation Pharmaceuticals's market cap is currently $429.82K. The company's EPS TTM is $-0.00; its P/E ratio is -0.01; Innovation Pharmaceuticals has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jun 23Jun 22Jun 21Jun 20Jun 19
Income Statement
Total Revenue$ 0.00$ 18.00K$ 0.00$ 423.00K$ 0.00
Gross Profit$ -373.00K$ 18.00K$ -378.00K$ 423.00K$ -371.00K
Operating Income$ -3.11M$ -6.92M$ -9.02M$ -4.63M$ -6.45M
EBITDA$ -2.74M$ -6.54M$ -8.64M$ -6.01M$ -6.11M
Net Income$ -3.17M$ -7.04M$ -13.87M$ -6.65M$ -9.07M
Balance Sheet
Cash & Short-Term Investments$ 1.52M$ 3.81M$ 10.19M$ 6.02M$ 579.00K
Total Assets$ 7.52M$ 10.38M$ 14.30M$ 9.25M$ 4.05M
Total Debt$ 725.00K$ 1.29M$ 1.87M$ 2.46M$ 1.92M
Net Debt$ -1.25M$ -2.52M$ -8.32M$ -3.56M$ 1.34M
Total Liabilities$ 5.48M$ 5.65M$ 6.79M$ 7.79M$ 8.18M
Stockholders' Equity$ 2.04M$ 4.73M$ 7.51M$ 1.46M$ -4.13M
Cash Flow
Free Cash Flow$ -2.17M$ -6.36M$ -9.57M$ -4.25M$ -6.42M
Operating Cash Flow$ -2.11M$ -6.28M$ -9.49M$ -4.16M$ -6.33M
Investing Cash Flow$ -60.00K$ -4.08M$ -72.00K$ -91.00K$ -46.00K
Financing Cash Flow$ -123.00K$ 3.97M$ 13.74M$ 9.69M$ 4.53M

Currency in USD

Innovation Pharmaceuticals Earnings and Revenue History

-20M-10M010M-45000 %-30000 %-15000 %0 %EarningsProfit Margin2017201820192020202120222023RevenueEarningsProfit Margin

Innovation Pharmaceuticals Liabilities to Assets

06M12M18M0 %80 %160 %240 %LiabilitiesLiabilities to Assets2017201820192020202120222023AssetsLiabilitiesLiabilities to Assets

Innovation Pharmaceuticals Cash Flow

-15M-10M-5M05M10M15M20M2017201820192020202120222023OperatingInvestingFinancing

Innovation Pharmaceuticals Forecast EPS vs Actual EPS

0Q3 18EPS EstimateBeatMiss